Pharmacia Vestra, Deramciclane Could Be Detailed By Specialized Rep Force
Pharmacia is considering creating a psychiatric sales force to promote its antidepressant Vestra (reboxetine), which is pending at FDA, as well as Orion Pharma's late-stage anxiety drug deramciclane.
You may also be interested in...
Pharmacia's experimental tumor necrosis factor inhibitor CDP-870 could gain a competitive advantage through a once-monthly dosing schedule
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011